Kovack Advisors’s AdaptHealth AHCO Stock Holding History

Kovack Advisors’s Portfolio AHCO Stock Details AHCO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-4,700	Closed	-$103K	–	618
2020 Q3	$103K	Buy	+4,700	New	+$98.7K	0.02%	460

Other funds holding AHCO

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

SAM

Silvercrest Asset Management New York $13.8B AUM 28.39% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

PCH

Polar Capital Holdings London, United Kingdom $28.2B AUM 115.26% 1-Year Est. Return

DCM

Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return

Principal Financial Group Des Moines, Iowa $187B AUM 18.48% 1-Year Est. Return

Maven Securities St Helier, Jersey $5.2B AUM 44.01% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Kovack Advisors's AHCO Position: Q4 2020 in Review

Kovack Advisors sold out of AdaptHealth (AHCO) in Q4 2020, closing a stake of 4,700 shares — an estimated $103K sold.

Kovack Advisors first reported a position in AHCO in Q3 2020 and held it in 1 quarter. The position peaked at $103K in Q3 2020. 134 funds tracked by Wall St. Rank hold AHCO as of Q4 2020.

Kovack Advisors reported no remaining AdaptHealth position as of Q4 2020 after selling out during the quarter.
Kovack Advisors sold 4,700 AdaptHealth shares in Q4 2020, an estimated $103K.
Kovack Advisors first reported a position in AdaptHealth in Q3 2020 and held it in 1 quarter.
Kovack Advisors's AdaptHealth position peaked at $103K in Q3 2020.
134 funds tracked by Wall St. Rank held AdaptHealth as of Q4 2020.

Based on Kovack Advisors's 13F filing for Q4 2020, filed 14 Jan 2021.